Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.

UVA researchers found that continuous glucose monitor data can predict nerve, eye, and kidney damage from type 1 diabetes.

Grifols has received a $21 million grant from The Michael J. Fox Foundation to fund a pioneering study aimed at identifying ...

Researchers at UVA have developed computer models to create targeted antibiotics, aiming to combat antibiotic resistance.

Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.

Enhance compliance and quality in the health and wellness market with Eurofins' GMP certification programme for dietary and ...

Discover Nuvia wPrime 2A Media, the advanced mixed-mode resin by Bio-Rad for efficient biomolecule purification at small to ...

Discover key considerations for executing workflows in drug discovery, from defining research questions and generating ...

LB Pharmaceuticals announced promising Phase II results for LB-102 in schizophrenia, demonstrating symptom improvement.

Kindeva and Emervax partner to develop painless vaccine delivery technology, targeting viruses like Yellow Fever, Ebola, and ...

A study by Mount Sinai and Memorial Sloan Kettering researchers uncovers how neurotransmitters regulate brain gene expression ...

Explore the molecular changes in Rett syndrome. Find out how this breakthrough could lead to more effective treatments.